Habeo Cell Therapy (ECCS-50) - Plus Therap
Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet Joint (clinicaltrials.gov) - Aug 8, 2020 - P=N/A; N=40; Recruiting; Sponsor: InGeneron, Inc.; Trial primary completion date: Jul 2020 ➔ Jul 2021 
Clinical • Trial primary completion date • Anesthesia • Immunology • Osteoarthritis • Pain • Rheumatology
http://clinicaltrials.gov/ct2/show/NCT03513731
 
Aug 8, 2020
 
Prev Next